Updates are available Correction dated 2022-10-18
Click to view Correction: https://doi.org/10.1007/s00268-022-06785-6
-
Authors
Hariri, Mahmoud http://orcid.org/0000-0002-8669-7026
Maaz, Bakry
Netfagi, Measser
Alawa, Jude
Sattouf, Ahmad
Dubies, Hussam Alden
Alahmad, Jehad
Seyitisa, Muhammet Fuat
Godier‐Furnemont, Amandine
Ghali, Abedalkarem
Ghandour, Ahmad
Abdullah, Zohair
Alsaleh, Munther
Almousa, Ibrahim
Habib, Waiel
Alshaer, Hisham http://orcid.org/0000-0001-6736-2215
-
Funding
Funding for this research was provided by:
Global Affairs Canada
Grand Challenges Canada
- License Information
-
More Information
Article History
Accepted: 1 August 2022
First Online: 29 September 2022
Change Date: 18 October 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00268-022-06785-6
Declarations
:
: Hariri, Alshaer, and Seyitisa receive financial compensation from Pragmatic Innovation Inc., the manufacturer of PragmaVAC devices used in this clinical trial, and have financial interest in its sales. Alshaer is the inventor and the owner of all intellectual property of PragmaVAC. All the other authors declare no conflicts of interest associated with this study.
: Informed consent was obtained from all participants included in the study, including consent for image capture.
: This study was reviewed and received approval from the Veritas Ethics Review Board, Montreal, Canada, on December 4, 2020 (ID# 2020–2377-3537–3).
: Trial NL9751 under title: <i>Validation of Manual Negative Pressure Wound Therapy for Open Wounds</i>, in Netherlands Trial Registry.
